CordovaCann - CEO, Taz Turner
CEO, Taz Turner
Source: CannabisFn
  • CordovaCann (CSE:CDVA) has, through its subsidiary Cordova Investments Canada, completed the acquisition of several cannabis retail assets
  • The assets, including intellectual property, were purchased from Starbuds International
  • The acquisition will allow CordovaCann to establish a cannabis retail platform and open a range of dispensaries in Western Canada
  • As consideration, the company has issued an initial 12,500,000 common shares for the acquisition
  • CordovaCann (CDVA) is currently steady at C$0.19 per share

CordovaCann (CSE:CDVA) has, through its subsidiary Cordova Investments Canada, completed the acquisition of several cannabis retail assets.

Pursuant to a letter of intent dated March 25 this year, the acquisition will allow the company to establish a cannabis retail platform under which it will open up to five recreational and four medical dispensaries in Western Canada.

The assets were purchased from British Columbia-based Starbuds International, and will continue to operate under the Starbuds brands for the time being.

The outlets will open over the next few months and will leverage Starbuds existing brand recognition and business model, which has seen considerable success in its US operations.

Starbuds USA currently operates 20 retail stores in three states, generating more than C$83.7 million in annual revenue.

As consideration for the acquisition, CordovaCann has issues an initial 12,500,000 common shares to Starbuds International.

A further 3,000,000 common shares will be issued for each additional Alberta-based lease assignment, up to a maximum of 6,000,000 shares.

The vendors will also receive 3,000,000 shares for the opening of each retail store, up to a maximum of 15,000,000 shares. However, the openings must be completed by April 8, 2021, in order to be eligible.

Taz Turner, CEO of CordovaCann, said that the acquisition is a significant milestone.

“The purchase of these assets is an exciting development in Cordova’s growth strategy, as it gives the company exclusive rights to leverage Starbuds’ exceptional brand name and operational expertise, developed in the US, into certain Canadian markets.

“Starbuds is a very successful cannabis retail operator in the US, and our plan for opening Starbuds stores in Canada is very attractive given the expected revenue and cash flow generation per store,” he added.

Separately, CordovaCann announced the appointment of seasoned cannabis industry veterans, Jakob Ripshtein and Ben Higham, to the company’s Board of Directors.

CordovaCann (CDVA) is currently steady at $0.19 per share at 10:44am EST.

More From The Market Online
Cannabis Report image of farmed cannabis plants

The Market Online’s Weekly Cannabis Report – July 26, 2024

Tilray Oral Solution THC10:CBD10 cannabis extract, aka Tilray Solução Oral THC10:CBD10, has been approved for medical use in Portugal.
medical branch logo

Tilray approved for third medical cannabis product in Portugal

Tilray Medical, a subsidiary of Tilray Brands (TSX:TLRY) has been approved for a new medical cannabis extract in Portugal.